Deficient glutamate tranport is associated with neurodegeneration in Alzheimer's disease

PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT

Lowry, O. H., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 315,771 · see citing works

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · see citing works

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

Munson, P. J., & Rodbard, D. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90515-1 · Cited by 8,494 · see citing works

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · see citing works

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · see citing works

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.3.631 · Cited by 2,668 · see citing works

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · see citing works

Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity

DeKosky, S. T., & Scheff, S. W. (1990) · Annals of Neurology · doi:10.1002/ana.410270502 · Cited by 2,376 · see citing works

Ionic dependence of glutamate neurotoxicity

Choi, D. W. (1987) · Journal of Neuroscience · doi:10.1523/jneurosci.07-02-00369.1987 · Cited by 1,854 · see citing works

Localization of neuronal and glial glutamate transporters

Rothstein, J. D., Martin, L. J., Levey, A. I., Dykes‐Hoberg, M., Jin, L., Wu, D. M., Nash, N. R., & Kuncl, R. W. (1994) · Neuron · doi:10.1016/0896-6273(94)90038-8 · Cited by 1,703 · see citing works

Selective loss of glial glutamate transporter GLT‐1 in amyotrophic lateral sclerosis

Rothstein, J. D., Van Kammen, M., Levey, A. I., Martin, L. J., & Kuncl, R. W. (1995) · Annals of Neurology · doi:10.1002/ana.410380114 · Cited by 1,471 · see citing works

Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles

Wiedenmann, B. J., & Franke, W. W. (1985) · Cell · doi:10.1016/s0092-8674(85)80082-9 · Cited by 1,432 · see citing works

Primary structure and functional characterization of a high-affinity glutamate transporter

Kanai, Y., & Hediger, M. A. (1992) · Nature · doi:10.1038/360467a0 · Cited by 1,339 · see citing works

Cloning and expression of a rat brain L-glutamate transporter

Pines, G., Danbolt, N. C., Bjørås, M., Zhang, Y., Bendahan, A., Eide, L., Koepsell, H., Storm‐Mathisen, J., Seeberg, E. C., & Kanner, B. I. (1992) · Nature · doi:10.1038/360464a0 · Cited by 1,232 · see citing works

Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene

Chartier-Harlin, M.-C., Crawford, F., Houlden, H., Warren, A., Hughes, D., Fidani, L., Goate, A., Rossor, M., Roques, P., Hardy, J., et al. (1991) · Nature · doi:10.1038/353844a0 · Cited by 1,214 · see citing works

Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain.

Storck, T., Schulte, S., Hofmann, K., & Stoffel, W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10955 · Cited by 1,185 · see citing works

A mutation in the Amyloid Precursor Protein Associated with Hereditary Alzheimer's Disease

Murrell, J. R., Farlow, M. R., Ghetti, B. F., & Benson, M. D. (1991) · Science · doi:10.1126/science.1925564 · Cited by 1,122 · see citing works

Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels.

Masters, C. L., Multhaup, G., Simms, G., Pottgiesser, J., Martins, R. N., & Beyreuther, K. T. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb04000.x · Cited by 1,043 · see citing works

The TINS/TiPS Lecture the molecular biology of mammalian glutamate receptor channels

Seeburg, P. H. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90093-2 · Cited by 881 · see citing works

A 38,000-dalton membrane protein (p38) present in synaptic vesicles.

Jahn, R., SCHIEBLER, W., Ouimet, C. C., & Greengard, P. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4137 · Cited by 851 · see citing works

A practical computer-based approach to the analysis of radioligand binding experiments

McPherson, G. A. (1983) · Computer Programs in Biomedicine · doi:10.1016/0010-468x(83)90031-4 · Cited by 823 · see citing works

Some morphometric aspects of the brain in senile dementia of the alzheimer type

Terry, R. D., Peck, A., DeTeresa, R., Schechter, R., & Horoupian, D. S. (1981) · Annals of Neurology · doi:10.1002/ana.410100209 · Cited by 801 · see citing works

Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein

Mattson, M. P., Cheng, B., Culwell, A. R., Esch, F. S., Lieberburg, I. M., & Rydel, R. E. (1993) · Neuron · doi:10.1016/0896-6273(93)90315-i · Cited by 795 · see citing works

Neurotransmitter enzyme abnormalities in senile dementia

Perry, E. K., Gibson, P. H., Blessed, G., Perry, R. H., & Tomlinson, B. E. (1977) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(77)90073-9 · Cited by 724 · see citing works

Perforant pathway changes and the memory impairment of Alzheimer's disease

Hyman, B. T., Van Hoesen, G. W., Kromer, L. J., & Damasio, A. R. (1986) · Annals of Neurology · doi:10.1002/ana.410200406 · Cited by 672 · see citing works

ULTRASTRUCTURAL STUDIES IN ALZHEIMER'S PRESENILE DEMENTIA.

Terry, R. D., Gonatas, N. K., & WEISS, M. (1964) · PubMed · Cited by 650 · see citing works

A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease

Davies, C. A., Mann, D. M. A., Sumpter, P. Q., & Yates, P. O. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90057-8 · Cited by 628 · see citing works

Calcium-destabilizing and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF

Mattson, M. P., Tomaselli, K. J., & Rydel, R. E. (1993) · Brain Research · doi:10.1016/0006-8993(93)90295-x · Cited by 379 · see citing works

Synaptic and neuritic alterations during the progression of Alzheimer's disease

Masliah, E., Mallory, M., Hansen, L., Richard, D., Alford, M., & Terry, R. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90121-x · Cited by 370 · see citing works

Secreted Forms of β‐Amyloid Precursor Protein Protect Against Ischemic Brain Injury

Smith‐Swintosky, V. L., Pettigrew, L. C., Craddock, S. D., Culwell, A. R., Rydel, R. E., & Mattson, M. P. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.63020781.x · Cited by 284 · see citing works

Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice

Mucke, L., Masliah, E., Johnson, W. B., Ruppe, M. D., Alford, M. F., Rockenstein, E. M., Forss‐Petter, S., Pietropaolo, M., Mallory, M. E., & Abraham, C. R. (1994) · Brain Research · doi:10.1016/0006-8993(94)90767-6 · Cited by 265 · see citing works

Localization of Alzheimer βA4 amyloid precursor protein at central and peripheral synaptic sites

SCHUBERT, W. J., Prior, R., Weidemann, A., Dircksen, H., Multhaup, G., Masters, C. L., & Beyreuther, K. T. (1991) · Brain Research · doi:10.1016/0006-8993(91)91532-6 · Cited by 265 · see citing works

Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid beta/A4 protein precursor.

Roch, J., Masliah, E., Roch‐Levecq, A., Sundsmo, M. P., Otero, D. A., Veinbergs, I., & Saitoh, T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7450 · Cited by 255 · see citing works

Patterns of aberrant sprouting in alzheimer's disease

Masliah, E., Mallory, M. E., Hansen, L. A., Alford, M. F., Albright, T., DeTeresa, R. M., Terry, R. D., Baudier, J., & Saitoh, T. (1991) · Neuron · doi:10.1016/0896-6273(91)90170-5 · Cited by 245 · see citing works

Research advances in Alzheimer's disease and related disorders

Iqbal, K., & Disorders, R. (1995) · Wiley eBooks · Cited by 229 · see citing works

Effect of Acute Stress on Hippocampal Glutamate Levels and Spectrin Proteolysis in Young and Aged Rats

Lowy, M. T., Wittenberg, L., & Yamamoto, B. K. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65010268.x · Cited by 217 · see citing works

Reactive synaptogenesis assessed by synaptophysin immunoreactivity is associated with GAP-43 in the dentate gyrus of the adult rat

Masliah, E., Fagan, A. M., Terry, R. D., DeTeresa, R. M., Mallory, M. E., & Gage, F. H. (1991) · Experimental Neurology · doi:10.1016/0014-4886(91)90169-d · Cited by 204 · see citing works

The elusive transporters with a high affinity for glutamate

Kanai, Y., Smith, C. P., & Hediger, M. A. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90094-3 · Cited by 198 · see citing works

Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in alzheimer's disease

Heinonen, O., Soininen, H., Sorvari, H., Kosunen, O., Paljärvi, L., Koivisto, E., & Riekkinen, P. J. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00422-2 · Cited by 186 · see citing works

Electrogenic Properties of the Epithelial and Neuronal High Affinity Glutamate Transporter

Kanai, Y., Nußberger, S., Romero, M. F., Boron, W. F., Hébert, S., & Hediger, M. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.28.16561 · Cited by 184 · see citing works

Three-dimensional analysis of the relationship between synaptic pathology and neuropil threads in Alzheimer disease

Masliah, E., Ellisman, M., Carragher, B., Mallory, M., Young, S., Hansen, L., Deteresa, R., & Terry, R. D. (1992) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199207000-00003 · Cited by 183 · see citing works

Untitled work

(1995) · PubMed · Cited by 167 · see citing works

Expression patterns of β‐amyloid precursor protein (β‐APP) in neural and nonneural human tissues from alzheimer's disease and control subjects

Arai, H., Lee, V. M. ‐., Messinger, M. L., Greenberg, B., Lowery, D. E., & Trojanowski, J. Q. (1991) · Annals of Neurology · doi:10.1002/ana.410300509 · Cited by 163 · see citing works

Synaptic pathology in alzheimer's disease: Immunological data for markers of synaptic and large dense-core vesicles

Lassmann, H., Weiler, R., Fischer, P. A., Bancher, C., Jellinger, K. A., Floor, E., Danielczyk, W., SEITELBERGER, F., & Winkler, H. J. S. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90003-k · Cited by 160 · see citing works

Immunocytochemical localization of the precursor protein for β-amyloid in the rat central nervous system

Card, J. P., Meade, R. P., & Davis, L. G. (1988) · Neuron · doi:10.1016/0896-6273(88)90131-6 · Cited by 155 · see citing works

Amyloid β protein precursor and the pathogenesis of Alzheimer's disease

Selkoe, D. J. (1989) · Cell · doi:10.1016/0092-8674(89)90093-7 · Cited by 154 · see citing works

The Role of Synaptic Proteins in the Pathogenesis of Disorders of the Central Nervous System

Masliah, E., & Terry, R. D. (1993) · Brain Pathology · doi:10.1111/j.1750-3639.1993.tb00728.x · Cited by 142 · see citing works

Brain spectrin, calpain and long-term changes in synaptic efficacy

LYNCH, G. S., & Baudry, M. (1987) · Brain Research Bulletin · doi:10.1016/0361-9230(87)90220-6 · Cited by 139 · see citing works

Spectrin subtypes in mammalian brain: an immunoelectron microscopic study

Zagon, I., Higbee, R. G., Riederer, B. M., & Goodman, S. R. (1986) · Journal of Neuroscience · doi:10.1523/jneurosci.06-10-02977.1986 · Cited by 136 · see citing works

Demonstration of glutamate/aspartate uptake activity in nerve endings by use of antibodies recognizing exogenous d-aspartate

Gundersen, V., Danbolt, N. C., Ottersen, O. P., & Storm‐Mathisen, J. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90114-u · Cited by 135 · see citing works

The neuronal and epithelial human high affinity glutamate transporter. Insights into structure and mechanism of transport.

Kanai, Y., Stelzner, M. G., Nußberger, S., Khawaja, S., Hébert, S., Smith, C. P., & Hediger, M. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32035-5 · Cited by 132 · see citing works

Mechanisms of Neurotrophic Factor Protection against Calcium- and Free Radical-Mediated Excitotoxic Injury: Implications for Treating Neurodegenerative Disorders

Mattson, M. P., Cheng, B., & Smith‐Swintosky, V. L. (1993) · Experimental Neurology · doi:10.1006/exnr.1993.1178 · Cited by 121 · see citing works

An antibody against phosphorylated neurofilaments identifies a subset of damaged association axons in Alzheimer's disease.

Masliah, E., Mallory, M. E., Hansen, L. A., Alford, M. F., DeTeresa, R. M., & Terry, R. D. (1993) · PubMed Central · Cited by 107 · see citing works

Molecular Genetics of Alzheimer's Disease

Clark, R. F., & Goate, A. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540110044004 · Cited by 100 · see citing works

Presynaptic and postsynaptic glutamatergic function in Alzheimer's disease

Cowburn, R. F., Hardy, J., Roberts‎, P., & BRIGGS, R. S. J. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90192-9 · Cited by 98 · see citing works

Localization of amyloid precursor protein in GAP43-immunoreactive aberrant sprouting neurites in Alzheimer's disease

Masliah, E., Mallory, M. E., Hansen, L. A., Alford, M. F., DeTeresa, R. M., Terry, R. D., Baudier, J., & Saitoh, T. (1992) · Brain Research · doi:10.1016/0006-8993(92)90831-s · Cited by 91 · see citing works

Delayed Antagonism of Calpain Reduces Excitotoxicity in Cultured Neurons

Brorson, J. R., Marcuccilli, C. J., & Miller, R. J. (1995) · Stroke · doi:10.1161/01.str.26.7.1259 · Cited by 89 · see citing works

Protection against HIV-1 gp120-induced brain damage by neuronal expression of human amyloid precursor protein.

Mucke, L., Abraham, C. R., Ruppe, M. D., Rockenstein, E. M., Toggas, S. M., Mallory, M. E., Alford, M. F., & Masliah, E. (1995) · The Journal of Experimental Medicine · doi:10.1084/jem.181.4.1551 · Cited by 88 · see citing works

Lesions of entorhinal cortex produce a calpain-mediated degradation of brain spectrin in dentate gyrus. I. Biochemical studies

Seubert, P. A., Ivy, G. O., Larson, J., Lee, J., Shahi, K., Baudry, M., & LYNCH, G. S. (1988) · Brain Research · doi:10.1016/0006-8993(88)90638-5 · Cited by 78 · see citing works

Variant Forms of Neuronal Glutamate Transporter Sites in Alzheimer's Disease Cerebral Cortex

Scott, H. L., Tannenberg, A. E. G., & Dodd, P. R. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64052193.x · Cited by 74 · see citing works

Regional changes in [3H]d-aspartate and [3H]TCP binding sites in Alzheimer's disease brains

Simpson, M. D. C., Royston, M. C., Deakin, J. F. W., Cross, A. J., Mann, D. M. A., & Slater, P. (1988) · Brain Research · doi:10.1016/0006-8993(88)90587-2 · Cited by 74 · see citing works

Heterogeneity of high affinity uptake of L-glutamate and L-aspartate in the mammalian central nervous system

Balcar, V. J., & Li, Y. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90556-5 · Cited by 63 · see citing works

A simple dot-immunobinding assay for quantification of synaptophysin-like immunoreactivity in human brain.

Alford, M. F., Masliah, E., Hansen, L. A., & Terry, R. D. (1994) · Journal of Histochemistry & Cytochemistry · doi:10.1177/42.2.8288869 · Cited by 63 · see citing works

Increased immunoreactivity of brain spectrin in Alzheimer disease: a marker for synapse loss?

Masliah, E., Iimoto, D. S., Saitoh, T., Hansen, L. A., & Terry, R. D. (1990) · Brain Research · doi:10.1016/0006-8993(90)90755-z · Cited by 61 · see citing works

Strong immunoreactivity of β-amyloid precursor protein, including the β-amyloid protein sequence, at human neuromuscular junctions

Askanas, V., Engel, W. K., & Alvarez, R. B. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90241-x · Cited by 55 · see citing works

Reduction of Neurological Damage by a Peptide Segment of the Amyloid β/A4 Protein Precursor in a Rabbit Spinal Cord Ischemia Model

Bowes, M. P., Masliah, E., Otero, D. A. C., Zivin, J. A., & Saitoh, T. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1152 · Cited by 54 · see citing works

The association of [3H]d-aspartate binding and high-affinity glutamate uptake in the human brain

Cross, A. J., Skan, W., & Slater, P. (1986) · Neuroscience Letters · doi:10.1016/0304-3940(86)90047-9 · Cited by 43 · see citing works

Glutamatergic neurotransmission in Alzheimer's disease

Cowburn, R. F., Hardy, J., & Roberts, P. J. J. (1990) · Biochemical Society Transactions · doi:10.1042/bst0180390 · Cited by 27 · see citing works

Glutamate/Aspartate-Releasing Neurons in Alzheimer's Disease

PROCTER, A. W., Palmer, A. M., Stratmann, G. C., & Bowen, D. M. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606263142617 · Cited by 24 · see citing works

Identification of Amyloid Precursor Protein in Synaptic Plasma Membrane

Shimokawa, M., Yanagisawa, K., Nishiye, H., & Miyatake, T. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2240 · Cited by 17 · see citing works

The American Society for Neural Transplantation

Sladek, J. R. (1994) · Experimental Neurology · doi:10.1006/exnr.1994.1141 · Cited by 15 · see citing works

Autoradiography of L-[3H]aspartate binding sites

Anderson, K. J., & Sandler, D. L. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90515-5 · Cited by 11 · see citing works

The Biological Function of Amyloid β/A4 Protein Precursor

Saitoh, T., Roch, J., Jin, L.-W., Ninomiya, H., Otero, D. A. C., Yamamoto, K., & Masliah, E. (1994) · Springer eBooks · doi:10.1007/978-3-662-01135-5_9 · Cited by 6 · see citing works

Glutamate uptake

Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,068 · see citing works

Role of Glutamate and NMDA Receptors in Alzheimer’s Disease

Wang, R., & Reddy, P. H. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160763 · Cited by 1,009 · see citing works

Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate Uptake

Li, S., Hong, S., Shepardson, N. E., Walsh, D. M., Shankar, G. M., & Selkoe, D. (2009) · Neuron · doi:10.1016/j.neuron.2009.05.012 · Cited by 972 · see citing works

Amyloid β-peptide (1-42)-induced Oxidative Stress and Neurotoxicity: Implications for Neurodegeneration in Alzheimer's Disease Brain. A Review

Allan Butterfield, D. (2002) · Free Radical Research · doi:10.1080/1071576021000049890 · Cited by 786 · see citing works

Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer’s disease brain contribute to neuronal death1

Allanbutterfield, D., Castegna, A., Lauderback, C. M., & Drake, J. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00340-2 · Cited by 715 · see citing works

Astrocytes Maintain Glutamate Homeostasis in the CNS by Controlling the Balance between Glutamate Uptake and Release

Mahmoud, S., Gharagozloo, M., Simard, C., & Gris, D. (2019) · Cells · doi:10.3390/cells8020184 · Cited by 698 · see citing works

Function and therapeutic value of astrocytes in neurological diseases

Lee, H.-G., Wheeler, M. A., & Quintana, F. J. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00390-x · Cited by 662 · see citing works

A vicious cycle of β amyloid−dependent neuronal hyperactivation

Zott, B., Simon, M. M., Hong, W., Unger, F., Chen-Engerer, H.-J., Frosch, M. P., Sakmann, B., Walsh, D. M., & Konnerth, A. (2019) · Science · doi:10.1126/science.aay0198 · Cited by 640 · see citing works

The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention

Sheldon, A. L., & Robinson, M. B. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2007.03.012 · Cited by 593 · see citing works

Proteomic identification of oxidatively modified proteins in Alzheimer’s disease brain. Part I: Creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1

Castegna, A., Aksenov, M., Aksenova, M., Thongboonkerd, V., Klein, J. B., Pierce, W. M., Booze, R., Markesbery, W. R., & Butterfield, D. A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00914-0 · Cited by 581 · see citing works

Extrasynaptic NMDA Receptor Involvement in Central Nervous System Disorders

Parsons, M. P., & Raymond, L. A. (2014) · Neuron · doi:10.1016/j.neuron.2014.03.030 · Cited by 555 · see citing works

Synaptic degeneration in Alzheimer's disease

Arendt, T. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0536-x · Cited by 517 · see citing works

Oxidative stress in the brain: Novel cellular targets that govern survival during neurodegenerative disease

Chong, Z. Z., Li, F., & Maiese, K. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.02.004 · Cited by 536 · see citing works

Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration

Zwilling, D., Huang, S., Sathyasaikumar, K. V., Notarangelo, F. M., Guidetti, P., Wu, H., Lee, J. H., Truong, J. K., Andrews-Zwilling, Y. S., Hsieh, E., et al. (2011) · Cell · doi:10.1016/j.cell.2011.05.020 · Cited by 519 · see citing works

Alzheimer's disease, β‐amyloid, glutamate, NMDA receptors and memantine – searching for the connections

Danysz, W., & Parsons, C. G. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02057.x · Cited by 500 · see citing works

Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease

Kaur, D., Sharma, V., & Deshmukh, R. R. (2019) · Inflammopharmacology · doi:10.1007/s10787-019-00580-x · Cited by 492 · see citing works

Excitotoxic mechanisms and the role of astrocytic glutamate transporters in traumatic brain injury

Yi, J., & Hazell, A. S. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2005.12.001 · Cited by 477 · see citing works

The glial glutamate transporter, GLT‐1, is oxidatively modified by 4‐hydroxy‐2‐nonenal in the Alzheimer's disease brain: the role of Aβ1–42

Lauderback, C. M., Hackett, J. M., Huang, F. F., Keller, J. N., Szweda, L. I., Markesbery, W. R., & Butterfield, D. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00451.x · Cited by 464 · see citing works

Elusive roles for reactive astrocytes in neurodegenerative diseases

Ben Haim, L., Carrillo-de Sauvage, M.-A., Ceyzériat, K., & Escartin, C. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00278 · Cited by 453 · see citing works

Neurotransmitter Transporters in the Central Nervous System

Masson, J., Sagné, C., Hamon, M., & Mestikawy, S. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01414-5 · Cited by 413 · see citing works

Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer’s Disease

Butterfield, D. A., & Boyd-Kimball, D. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170543 · Cited by 403 · see citing works

The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence

Danysz, W., & Parsons, C. G. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.938 · Cited by 404 · see citing works

High Affinity Glutamate Transporters: Regulation of Expression and Activity

Gegelashvili, G., & Schousboe, A. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.1.6 · Cited by 398 · see citing works

Prominent axonopathy in the brain and spinal cord of transgenic mice overexpressing four-repeat human tau protein.

Spittaels, K., den Haute, C. V., Dorpe, J. V., Bruynseels, K., Vandezande, K., Laenen, I., Geerts, H., Mercken, M., Sciot, R., Lommel, A. V. V., et al. (1999) · American Journal of Pathology · doi:10.1016/s0002-9440(10)65533-2 · Cited by 405 · see citing works

Transporters for L‐glutamate: An update on their molecular pharmacology and pathological involvement

Beart, P., & O'Shea, R. D. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706949 · Cited by 419 · see citing works

Glutamate transporters: animal models to neurologic disease

Maragakis, N. J., & Rothstein, J. D. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.007 · Cited by 352 · see citing works

Astrocytes: Role and Functions in Brain Pathologies

Siracusa, R., Fusco, R., & Cuzzocrea, S. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01114 · Cited by 342 · see citing works

Astrocyte phenotype in relation to Alzheimer‐type pathology in the ageing brain

Simpson, J. E., Ince, P. G., Lace, G., Forster, G., Shaw, P. J., Matthews, F., Savva, G., Brayne, C., & Wharton, S. B. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.05.015 · Cited by 381 · see citing works

Glutamate Transporters in Neurologic Disease

Maragakis, N. J., & Rothstein, J. D. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.365 · Cited by 324 · see citing works

Impaired glutamate transport and glutamate-glutamine cycling: downstream effects of the Huntington mutation

Behrens, P. F. (2002) · Brain · doi:10.1093/brain/awf180 · Cited by 322 · see citing works

Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type

Law, A. (2001) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00051-5 · Cited by 312 · see citing works

Neuroinflammation in Alzheimer’s Disease

Onyango, I. G., Jauregui, G. V., Čarná, M., Bennett, J. P., & Stokin, G. B. (2021) · Biomedicines · doi:10.3390/biomedicines9050524 · Cited by 330 · see citing works

Glutamate system, amyloid β peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology

Revett, T. J., Baker, G. B., Jhamandas, J. H., & Kar, S. (2012) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.110190 · Cited by 294 · see citing works

Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice

Guo, H. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg267 · Cited by 283 · see citing works

The Glutamatergic System and Alzheimer???s Disease

Butterfield, D. A., & Pocernich, C. B. (2003) · CNS Drugs · doi:10.2165/00023210-200317090-00004 · Cited by 267 · see citing works

The critical role of methionine 35 in Alzheimer's amyloid β-peptide (1–42)-induced oxidative stress and neurotoxicity

Butterfield, D. A., & Debra Boyd-kimball, A. (2004) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2004.10.014 · Cited by 267 · see citing works

Molecular mechanisms of cognitive dysfunction following traumatic brain injury

Walker, K. R., & Tesco, G. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00029 · Cited by 265 · see citing works

Distribution of glutamate transporters in the hippocampus of patients with pharmaco‐resistant temporal lobe epilepsy

Proper, E. A., Hoogland, G., Kappen, S. M., Jansen, G. H., Rensen, M. G. A., Schrama, L. H., Veelen, C. W. M. V., van Rijen, P. C., van Nieuwenhuizen, O., Gispen, W. H., et al. (2002) · Brain · doi:10.1093/brain/awf001 · Cited by 264 · see citing works

Amyloid β‐Peptide(1‐42) Contributes to the Oxidative Stress and Neurodegeneration Found in Alzheimer Disease Brain

Butterfield, D. A., & Debra Boyd-kimball, A. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00087.x · Cited by 263 · see citing works

Protein Oxidation and Lipid Peroxidation in Brain of Subjects with Alzheimer's Disease: Insights into Mechanism of Neurodegeneration from Redox Proteomics

Rukhsana Sultana, A., Marzia Perluigi, A., & Butterfield, D. A. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.2021 · Cited by 261 · see citing works

Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer’s disease

Ceyzériat, K., Ben Haim, L., Denizot, A., Pommier, D., Matos, M., Guillemaud, O., Palomares, M.-A., Abjean, L., Petit, F., Gipchtein, P., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0606-1 · Cited by 256 · see citing works

Astrocyte energy and neurotransmitter metabolism in Alzheimer’s disease: Integration of the glutamate/GABA-glutamine cycle

Andersen, J. V., Schousboe, A., & Verkhratsky, A. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102331 · Cited by 259 · see citing works

Astrocyte dysfunction in Alzheimer disease

Acosta, C., Anderson, H. D., & Anderson, C. M. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24075 · Cited by 248 · see citing works

Antioxidants in Central Nervous System Diseases: Preclinical Promise and Translational Challenges

Kamat, C. D., Gadal, S., Mhatre, M., Williamson, K. S., Pye, Q. N., & Hensley, K. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-15314 · Cited by 237 · see citing works

Targeting Neuroinflammation to Treat Alzheimer’s Disease

Ardura-Fabregat, A., Boddeke, E., Boza‐Serrano, A., Brioschi, S., Castro‐Gomez, S., Ceyzériat, K., Dansokho, C., Dierkes, T., Gelders, G., Heneka, M. T., et al. (2017) · CNS Drugs · doi:10.1007/s40263-017-0483-3 · Cited by 236 · see citing works

Glial transporters for glutamate, glycine and GABA I. Glutamate transporters

Gadea, A., & López-Colomé, A. M. (2001) · Journal of Neuroscience Research · doi:10.1002/jnr.1039 · Cited by 227 · see citing works

Motor cortex excitability in Alzheimer's disease: A transcranial magnetic stimulation study

Ferreri, F., Pauri, F., Pasqualetti, P., Fini, R., Forno, G. D., & Rossini, P. M. (2002) · Annals of Neurology · doi:10.1002/ana.10416 · Cited by 223 · see citing works

Amyloid-beta peptide decreases glutamate uptake in cultured astrocytes: Involvement of oxidative stress and mitogen-activated protein kinase cascades

Matos, M., Augusto, E., Oliveira, C. R., & Agostinho, P. M. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.022 · Cited by 223 · see citing works

Glutamate transporter EAAT2: regulation, function, and potential as a therapeutic target for neurological and psychiatric disease

Takahashi, K., Foster, J. B., & Lin, C. G. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1937-8 · Cited by 213 · see citing works

Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain

Butterfield, D. A. (2004) · Brain Research · doi:10.1016/j.brainres.2003.12.012 · Cited by 210 · see citing works

d-glutamate and Gut Microbiota in Alzheimer’s Disease

Chang, C.-H., Lin, C.-H., & Lane, H.-Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082676 · Cited by 191 · see citing works

Carbonyl Toxicology and Alzheimer's Disease

Picklo, M. J. (2002) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2002.9506 · Cited by 194 · see citing works

Altered Glutamate Reuptake in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis Cortex: Correlation With Microglia Infiltration, Demyelination, and Neuronal and Synaptic Damage

Vercellino, M., Merola, A., Piacentino, C., Votta, B., Capello, E., Mancardi, G. L., Mutani, R., Giordana, M. T., & Cavalla, P. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31812571b0 · Cited by 190 · see citing works

The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain

Gąsiorowska, A., Wydrych, M., Drapich, P., Zadrożny, M., Steczkowska, M., Niewiadomski, W., & Niewiadomska, G. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.654931 · Cited by 192 · see citing works

Amyloid-β _1–42 Slows Clearance of Synaptically Released Glutamate by Mislocalizing Astrocytic GLT-1

Scimemi, A., Meabon, J. S., Woltjer, R. L., Sullivan, J. M., Diamond, J. S., & Cook, D. G. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.5274-12.2013 · Cited by 185 · see citing works

Memantine Improves Spatial Learning in a Transgenic Mouse Model of Alzheimer’s Disease

Minkeviciene, R., Banerjee, P., & Tanila, H. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.071027 · Cited by 184 · see citing works

Lipid homeostasis and apolipoprotein E in the development and progression of Alzheimer's disease

Lane, R. M., & Farlow, M. R. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m400486-jlr200 · Cited by 182 · see citing works

Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration

Butterfield, D. A., Debra Boyd-kimball, A., & Castegna, A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01948.x · Cited by 183 · see citing works

Reactive astrocytes: The nexus of pathological and clinical hallmarks of Alzheimer’s disease

Price, B. R., Johnson, L. A., & Norris, C. M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101335 · Cited by 173 · see citing works

Environmental enrichment prevents astroglial pathological changes in the hippocampus of APP transgenic mice, model of Alzheimer's disease

Beauquis, J., Pavía, P., Pomilio, C. J., Vinuesa, Á., Podlutskaya, N., Galván, V., & Saravia, F. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.09.009 · Cited by 177 · see citing works

Amyloid β-peptide and amyloid pathology are central to the oxidative stress and inflammatory cascades under which Alzheimer's disease brain exists

Butterfield, D. A., Griffin, S. T., Münch, G. W., & Pasinetti, G. M. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4309 · Cited by 174 · see citing works

Glutamate–glutamine cycling in Alzheimer's disease

WALTON, H., & DODD, P. (2007) · Neurochemistry International · doi:10.1016/j.neuint.2006.10.007 · Cited by 174 · see citing works

GluN2B subunit-containing NMDA receptor antagonists prevent Aβ-mediated synaptic plasticity disruption in vivo

Hu, N., Klyubin, I. V., Anwyl, R., & Rowan, M. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908083106 · Cited by 171 · see citing works

Excitatory Amino Acid Transporters in Physiology and Disorders of the Central Nervous System

Malik, A. R., & Willnow, T. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225671 · Cited by 170 · see citing works

Redox Proteomics in Selected Neurodegenerative Disorders: From Its Infancy to Future Applications

Butterfield, D. A., Marzia Perluigi, A., Reed, T. T., Muharib, T., Hughes, C. P., Robinson, R. A. S., & Rukhsana Sultana, A. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4109 · Cited by 167 · see citing works

The Regulation of Astrocytic Glutamate Transporters in Health and Neurodegenerative Diseases

Todd, A., & Hardingham, G. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249607 · Cited by 169 · see citing works

GLT-1 Loss Accelerates Cognitive Deficit Onset in an Alzheimer's Disease Animal Model

Mookherjee, P., Green, P. S., Watson, G. S., Marques, M. A., Tanaka, K., Meeker, K. D., Meabon, J. S., Li, N., Zhu, P., Olson, V. G., et al. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110503 · Cited by 166 · see citing works

Reduced glutamine synthetase in hippocampal areas with neuron loss in temporal lobe epilepsy

van der Hel, W. S., Notenboom, R. G. E., Bos, I. W. M., van Rijen, P. C., Veelen, C. W. M. V., & Graan, P. N. E. D. (2005) · Neurology · doi:10.1212/01.wnl.0000149636.44660.99 · Cited by 166 · see citing works

Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid β-peptide (1–42) into rat brain: Implications for Alzheimer’s disease

Debra Boyd-kimball, A., Rukhsana Sultana, A., Poon, H. F., Lynn, B. C., Casamenti, F., Pepeu, G., Klein, J. B., & Butterfield, D. A. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.12.022 · Cited by 166 · see citing works

Glutamate transporter variants reduce glutamate uptake in Alzheimer's disease

Scott, H. A., Gebhardt, F. M., Mitrovic, A. D., Vandenberg, R. J., & Dodd, P. R. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.03.008 · Cited by 202 · see citing works

Role of By-Products of Lipid Oxidation in Alzheimer's Disease Brain: A Focus on Acrolein

Singh, M., Nam, D. T., Arseneault, M., & Ramassamy, C. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-100405 · Cited by 162 · see citing works

Soluble Aβ oligomers impair hippocampal LTP by disrupting glutamatergic/GABAergic balance

Lei, M., Xu, H., Li, Z., Wang, Z., O’Malley, T. T., Zhang, D., Walsh, D. M., Xu, P., Selkoe, D. J., & Li, S. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.10.019 · Cited by 162 · see citing works

Transforming growth factor-beta inhibition of cytokine-induced vascular cell adhesion molecule-1 expression in human astrocytes

Winkler, M. K., & Benveniste, E. N. (1998) · Glia · doi:10.1002/(sici)1098-1136(199802)22:2 · Cited by 50 · see citing works

Mapping synaptic glutamate transporter dysfunction in vivo to regions surrounding Aβ plaques by iGluSnFR two-photon imaging

Hefendehl, J. K., LeDue, J. M., Ko, R. W. Y., Mahler, J., Murphy, T. H., & MacVicar, B. A. (2016) · Nature Communications · doi:10.1038/ncomms13441 · Cited by 157 · see citing works

The solute carrier transporters and the brain: Physiological and pharmacological implications

Hu, C., Tao, L., Cao, X., & Chen, L. (2019) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2019.09.002 · Cited by 157 · see citing works

Restored glial glutamate transporter EAAT2 function as a potential therapeutic approach for Alzheimer’s disease

Takahashi, K., Kong, Q., Lin, Y., Stouffer, N., Schulte, D. A., Lai, L., Liu, Q., Chang, L., Dominguez, S., Xing, X., et al. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20140413 · Cited by 157 · see citing works

Activated astroglia during chronic inflammation in Alzheimer's disease—Do they neglect their neurosupportive roles?

Fuller, S. L., Steele, M. L., & Münch, G. W. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.08.016 · Cited by 155 · see citing works

Pyrrolidine Dithiocarbamate Activates Akt and Improves Spatial Learning in APP/PS1 Mice without Affecting β-Amyloid Burden

Malm, T., Iivonen, H., Goldsteins, G., Keksa-Goldsteine, V., Ahtoniemi, T., Kanninen, K. M., Salminen, A., Auriola, S. O. K., van Groen, T., Tanila, H., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.0059-07.2007 · Cited by 154 · see citing works

Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease

Zumkehr, J., Rodríguez‐Ortiz, C. J., Cheng, D., Kieu, Z., Wai, T., Hawkins, C., Kilian, J., Lim, S., Medeiros, R., & Kitazawa, M. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.04.005 · Cited by 152 · see citing works

Astrocyte elevated gene-1: Recent insights into a novel gene involved in tumor progression, metastasis and neurodegeneration

Emdad, L., Sarkar, D., Su, Z.-Z., Lee, S., Kang, D., Bruce, J. N., Volsky, D. J., & Fisher, P. B. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.01.010 · Cited by 151 · see citing works

Advances in the Potential Biomarkers of Epilepsy

Kobylarek, D., Iwanowski, P. S., Lewandowska, Z., Limphaibool, N., Szafranek, S., Labrzycka, A., & Kozubski, W. P. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00685 · Cited by 153 · see citing works

Detrimental effects of chronic hypothalamic—pituitary—adrenal axis activation

Raber, J. (1998) · Molecular Neurobiology · doi:10.1007/bf02741457 · Cited by 149 · see citing works

Glutamate Transporter EAAT2: A New Target For The Treatment Of Neurodegenerative Diseases

Lin, C. G., Kong, Q., Cuny, G. D., & Glicksman, M. A. (2012) · Future Medicinal Chemistry · doi:10.4155/fmc.12.122 · Cited by 147 · see citing works

Brain excitability and connectivity of neuronal assemblies in Alzheimer's disease: From animal models to human findings

D’Amelio, M., & Rossini, P. M. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.07.001 · Cited by 144 · see citing works

Abnormal Glutamate Transport Function in Mutant Amyloid Precursor Protein Transgenic Mice

Masliah, E., Alford, M. F., Mallory, M. E., Rockenstein, E. M., Moechars, D., & LEUVEN, F. V. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7386 · Cited by 145 · see citing works

Estrogen and tamoxifen reverse manganese‐induced glutamate transporter impairment in astrocytes

Lee, E.-S., Sidoryk‐Wȩgrzynowicz, M., Jiang, H., Yin, Z., & Aschner, M. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06105.x · Cited by 143 · see citing works

Proteomic identification of proteins oxidized by Aβ(1–42) in synaptosomes: Implications for Alzheimer's disease

Debra Boyd-kimball, A., Castegna, A., Rukhsana Sultana, A., Poon, H. F., Petroze, R. T., Lynn, B. C., Klein, J. B., & Butterfield, D. A. (2005) · Brain Research · doi:10.1016/j.brainres.2005.02.086 · Cited by 142 · see citing works

Effects of estrogen treatment on glutamate uptake in cultured human astrocytes derived from cortex of Alzheimer's disease patients

Liang, Z., Valla, J., Sefidvash-Hockley, S., Rogers, J., & Li, R. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2002.00779.x · Cited by 141 · see citing works

Chloride, carboxylate and carbonate transport by ortho-phenylenediamine-based bisureas

Moore, S. J., Haynes, C. J. E., González‐García, J., Sutton, J. L., Brooks, S. J., Light, M. E., Herniman, J., Langley, G. J., Soto‐Cerrato, V., Pérez‐Tomás, R., et al. (2012) · Chemical Science · doi:10.1039/c2sc21112b · Cited by 139 · see citing works

Pathological phenotypes of astrocytes in Alzheimer’s disease

Kim, J., Yoo, I. D., Lim, J., & Moon, J. (2024) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01148-0 · Cited by 146 · see citing works

Reactive astrocytes give neurons less support: implications for Alzheimer's disease

Steele, M. L., & Robinson, S. R. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.09.018 · Cited by 138 · see citing works

Overview of Glutamatergic Dysregulation in Central Pathologies

Miladinovic, T., Nashed, M. G., & Singh, G. (2015) · Biomolecules · doi:10.3390/biom5043112 · Cited by 135 · see citing works

Intracellular Calcium Dysregulation: Implications for Alzheimer’s Disease

Magi, S., Castaldo, P., Macrì, M. L., Maiolino, M., Matteucci, A., Bastioli, G., Gratteri, S., Amoroso, S., & Lariccia, V. (2016) · BioMed Research International · doi:10.1155/2016/6701324 · Cited by 137 · see citing works

Astrocytes in mouse models of tauopathies acquire early deficits and lose neurosupportive functions

Sidoryk‐Wȩgrzynowicz, M., Gerber, Y. N., Ries, M., Sastre, M., Tolkovsky, A. M., & Spillantini, M. G. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0478-9 · Cited by 137 · see citing works

Functional and structural damage of neurons by innate immune mechanisms during neurodegeneration

Ising, C., & Heneka, M. T. (2018) · Cell Death and Disease · doi:10.1038/s41419-017-0153-x · Cited by 136 · see citing works

Minocycline prevents neurotoxicity induced by cerebrospinal fluid from patients with motor neurone disease

Tikka, T., Vartiainen, N. E., Goldsteins, G., Oja, S. S., Andersen, P. M., Marklund, S. L., & Koıstınaho, J. (2002) · Brain · doi:10.1093/brain/awf068 · Cited by 136 · see citing works

Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: Implications for Aβ accumulation in AD brain

Owen, J. B., Rukhsana Sultana, A., Aluise, C. D., Erickson, M. A., Price, T. O., Bu, G., Banks, W. A., & Butterfield, D. A. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.013 · Cited by 130 · see citing works

The excitatory amino acid transporters: Pharmacological insights on substrate and inhibitor specificity of the EAAT subtypes

Bridges, R. J., & Esslinger, C. S. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.01.002 · Cited by 130 · see citing works

The 2013 SFRBM Discovery Award: Selected discoveries from the Butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment

Butterfield, D. A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.006 · Cited by 126 · see citing works

Blood-brain barrier integrity in the pathogenesis of Alzheimer’s disease

Huang, Z., Wong, L., Su, Y., Huang, X., Wang, N., Chen, H., & Yi, C. (2020) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2020.100857 · Cited by 130 · see citing works

The glial glutamate transporter, GLT‐1, is oxidatively modified by 4‐hydroxy‐2‐nonenal in the Alzheimer's disease brain: the role of Aβ1–42

Lauderback, C. M., Hackett, J. M., Huang, F. F., Keller, J. N., Szweda, L. I., Markesbery, W. R., & Butterfield, D. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00451.x · Cited by 464 · see citing works

The Identification and Characterization of Excitotoxic Nerve-endings in Alzheimer Disease

Tannenberg, R. K., Scott, H. L., Westphalen, R. I., & Dodd, P. R. (2004) · Current Alzheimer Research · doi:10.2174/1567205043480591 · Cited by 37 · see citing works

Regional changes in [3H]d-aspartate and [3H]TCP binding sites in Alzheimer's disease brains

Simpson, M. D. C., Royston, M. C., Deakin, J. F. W., Cross, A. J., Mann, D. M. A., & Slater, P. (1988) · Brain Research · doi:10.1016/0006-8993(88)90587-2 · Cited by 74 · see citing works

Variant Forms of Neuronal Glutamate Transporter Sites in Alzheimer's Disease Cerebral Cortex

Scott, H. L., Tannenberg, A. E. G., & Dodd, P. R. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64052193.x · Cited by 74 · see citing works

P3–199: The glutamate transporter, EAAT3 (EAAC1), is aberrantly expressed in hippocampus of individuals with Alzheimer's disease

Cook, D. G., Deurson, K., Leverenz, J. B., Bird, T. D., Montine, T. J., & Pow, D. V. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.1467